Trinity Biotech TRIB Estimates

NASDAQ TRIB
$5.28 -0.42 (-7.37%)
At close: Nov 9, 2026 · 4:00 PM EST
Analyst Estimates

Trinity Biotech Plc Revenue Estimates

Periods 14
Next Period Q1 25
Consensus 15.25 M

Analysts expect Trinity Biotech Plc to report revenue of 15.25 M for Q1 25, against a range of 14.23 M to 16.26 M. The most recent reported quarter, Q4 24, came in at 15.86 M, a 6.2% miss against the 16.90 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) 15.15 M15.86 M--------
High Estimate 18.33 M17.86 M16.26 M11.66 M14.35 M15.50 M16.62 M12.07 M15.72 M15.76 M
Low Estimate 15.35 M15.95 M14.23 M10.65 M12.83 M13.51 M15.36 M10.50 M13.77 M14.07 M
Consensus Estimate 16.84 M16.90 M15.25 M11.15 M13.59 M14.50 M15.99 M11.29 M14.74 M14.91 M
Analyst Estimates

Trinity Biotech Plc Earnings Per Share (EPS) Estimates

Periods 14
Next Period Q1 25
Consensus -8.75

Analysts expect Trinity Biotech Plc to report earnings per share of -8.75 for Q1 25, against a range of -9.45 to -8.05. The most recent reported quarter, Q4 24, came in at -37.06, a 324.0% miss against the -8.74 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27
Reported (Actual) -13.74-37.06--------
High Estimate -14.23-8.27-8.05-14.76-9.94-8.16-8.53-7.79-7.73-6.30
Low Estimate -16.75-9.21-9.45-16.86-11.22-9.80-9.67-8.43-8.49-7.68
Consensus Estimate -15.49-8.74-8.75-15.81-10.58-8.98-9.10-8.11-8.11-6.99

Trinity Biotech Plc Estimates API

Pull Wall Street consensus for Trinity Biotech Plc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=TRIB&mode=revenue&api_key=YOUR_API_KEY